Internal Medicine, Infectious Disease · Madison, WI
NPI
1538106828
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1211 Fish Hatchery Rd
Madison, WI, 53715
Phone (608) 252-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$927K
85,982 services
Medicare patients, 2024
484
Average age 73
Drug cost, 2024
$959K
1,249 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Garry Jean-Louis was code Q5104 (injection, infliximab-abda, biosimilar, (renflexis), 10 mg), 2,950 times for 28 patients. In total Garry Jean-Louis billed 85,982 services in 101 codes, and Medicare paid $927K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 2,950 | 28 | $23.10 | $68K |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,200 | 13 | $2.18 | $2,620 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 856 | 20 | $0.36 | $306 |
| 96365 Intravenous Infusion, Hydration | Office | 270 | 99 | $45.09 | $12K |
| 99214 Office E&M - Established | Office | 263 | 133 | $90.33 | $24K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 248 | 16 | $0.22 | $55.43 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 240 | 48 | $4.73 | $1,135 |
| 85025 Blood Count | Office | 105 | 35 | $7.61 | $799 |
| 36415 Venipuncture Blood Collection | Office | 104 | 51 | $8.65 | $900 |
| 96413 Chemotherapy Administration | Office | 104 | 49 | $87.37 | $9,087 |
| 96375 Injection Administration | Office | 95 | 32 | $10.81 | $1,027 |
| 99233 Hospital E&M - Subsequent | Facility | 83 | 59 | $86.44 | $7,175 |
| 96415 Chemotherapy Administration | Office | 61 | 24 | $18.37 | $1,121 |
| 99223 Hospital E&M - Initial | Facility | 50 | 49 | $127.68 | $6,384 |
| 51720 Chemotherapy Administration | Office | 49 | 26 | $64.25 | $3,148 |
By year: 2022 $980K for 74,918 services; 2023 $899K for 88,071 services; 2024 $927K for 85,982 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 105 | 35 | $7.61 | $799 |
| 36415 Venipuncture Blood Collection | 104 | 51 | $8.65 | $900 |
| 85652 Clinical Chemistry | 19 | 13 | $2.65 | $50.35 |
Medicare prescription drug claims, 2024
In 2024, the drug Garry Jean-Louis prescribed most often to Medicare patients was Doxycycline Hyclate, with 143 prescriptions and refills. In total Garry Jean-Louis wrote 1,249 Medicare prescriptions that cost $959K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 143 | 204 | 33 | $2,630 |
| Methenamine Hippurate Generic | 97 | 139 | 16 | $6,284 |
| Cephalexin Generic | 84 | 131 | 16 | $1,271 |
| Amoxicillin Generic | 80 | 122 | 27 | $1,192 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 61 | 69 | Under 11 | $277K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 45 | 79 | 12 | $541 |
| Vancomycin Hcl Generic | 43 | 59 | 12 | $3,909 |
| Rifampin Generic | 35 | 40 | Under 11 | $2,142 |
| Dicloxacillin Sodium Generic | 32 | 39 | Under 11 | $3,277 |
| Ceftriaxone Ceftriaxone Sodium | 32 | 32 | Under 11 | $1,170 |
| Cefadroxil Generic | 29 | 39 | Under 11 | $662 |
| Ethambutol Hcl Generic | 27 | 32 | Under 11 | $1,555 |
| Ciprofloxacin Hcl Generic | 27 | 27 | 12 | $319 |
| Cefazolin Sodium Generic | 25 | 25 | Under 11 | $769 |
| Ertapenem Ertapenem Sodium | 25 | 25 | Under 11 | $15K |
Brand drugs: 196 claims; generic drugs: 1,053 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Garry Jean-Louis were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.